Markets:

Overview

News

Currencies

International

Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

49.23 +2.27 (+4.84%)

Streaming Delayed Price Updated: 3:17 PM EDT, Mar 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

7 Analysts Have This To Say About Tempus AI ↗

September 26, 2025

Tempus AI (NASDAQ: TEM) has been analyzed by 7 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ratings,...

Via Benzinga

Topics Artificial Intelligence

Why Tempus AI Stock Is Plunging This Week ↗

September 25, 2025

When a well-known growth investor decides to trim her position in a stock, investors sit up and take note.

Via The Motley Fool

Topics Artificial Intelligence ETFs

Cathie Wood Makes Trading Blitz: Buys Alibaba Stock Woth $11 Million, Dumps AMD And This AI Stock ↗

September 24, 2025

On Wednesday Sept. 24, 2025, Cathie Wood-led Ark Invest purchased nearly $11 million worth of Alibaba stock while selling shares of AMD and Tempus AI.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead ↗

September 23, 2025

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

Via Benzinga

Topics Artificial Intelligence

IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance ↗

September 22, 2025

The company is focusing on RNA sequencing as a means of assisting with drug development.

Via Investor's Business Daily

Topics Artificial Intelligence Intellectual Property

Tempus AI (TEM) Stock Is Rising Monday: What's Going On? ↗

September 22, 2025

Tempus AI shares are trading higher Monday morning. The company announced it has received U.S. Food and Drug Administration 510(k) clearance for its RNA-based Tempus xR IVD device.

Via Benzinga

Topics Artificial Intelligence

3 Big Short Interest Names with Bullish Setups ↗

September 22, 2025

HIMS, DLO, and TEM combine high short interest with bullish chart setups, creating strong breakout potential as market momentum stays hot.

Via MarketBeat

Topics Artificial Intelligence

Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device

September 22, 2025

From Tempus AI, Inc.

Via Business Wire

Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗

September 18, 2025

On Thursday, Cathie Wood-led Ark Invest executed significant trades, notably selling shares of Tempus AI Inc (NASDAQ:TEM) and buying shares of Brera Holdings PLC (NASDAQ:BREA),

Via Benzinga

Topics Artificial Intelligence

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

September 18, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:CRSP),(NASDAQ:BNTX),(NYSE:BMY) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence

Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI ↗

September 16, 2025

On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o

Via Benzinga

What's Going On With Tempus AI Stock Monday? ↗

September 15, 2025

Tempus AI stock is trading marginally lower on Monday. Recent bullish sentiment follows last Thursday's announcement that Tempus AI received 510(k) clearance from the FDA.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood's Ark Pivots: Sells Tempus AI After FDA Win, Loads Up On Amazon, Figma And This Trendy Crypto Stock ↗

September 11, 2025

Cathie Wood-led Ark Invest sold shares of Tempus AI, bought Bullish, Amazon, and Figma. The moves align with recent achievements and advancements of the companies.

Via Benzinga

Topics Artificial Intelligence

Why Tempus AI Stock Soared Nearly 14% Higher Today ↗

September 11, 2025

The AI heathcare tech specialist is about to put another product on the market.

Via The Motley Fool

Topics Artificial Intelligence

Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging ↗

September 11, 2025

Tempus AI's Tempus Pixel received FDA clearance for cardiac imaging updates, adding T1/T2 maps to enhance MR image analysis and diagnosis precision.

Via Benzinga

Topics Artificial Intelligence

Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move ↗

September 11, 2025

Shares jumped into a profit-taking zone Thursday after the FDA cleared its updated cardiac-imaging platform.

Via Investor's Business Daily

Topics Artificial Intelligence

Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday ↗

September 11, 2025

Via Benzinga

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

September 11, 2025

From Tempus AI, Inc.

Via Business Wire

Why Are Stock Market Investors Talking About TempusAI Stock? ↗

September 10, 2025

Artificial intelligence is the hottest investing trend of 2025.

Via The Motley Fool

Topics Artificial Intelligence

Stock Market Investors Want to Know: What's Going on With TempusAI Stock? ↗

September 10, 2025

Revenue growth is soaring for TempusAI, and that has investors excited.

Via The Motley Fool

Cathie Wood's Ark Dumps $2.1 Million Of This Hot AI Stock Despite Recent Acquisition Boost ↗

September 09, 2025

On Tuesday, Cathie Wood-led Ark Invest sold shares of Tempus AI Inc (NASDAQ: TEM) through ARK Genomic Revolution ETF (ARKG) and ARK Innovation ETF (ARKK) totaling $2.1 million. This follows Tempus AI's...

Via Benzinga

Topics Artificial Intelligence ETFs

Tempus Announces New Study in JCO Precision Oncology Validating PurIST® Algorithm for Enhanced Therapy Selection in Pancreatic Cancer

September 09, 2025

From Tempus AI, Inc.

Via Business Wire

TEMPUS AI INC (NASDAQ:TEM) Excels on Minervini Trend Template with High Growth Momentum ↗

September 08, 2025

Tempus AI (TEM) excels with a perfect technical rating, accelerating revenue growth of 89.57%, and strong earnings momentum, fitting the high-growth Minervini Trend Template.

Via Chartmill

Topics Artificial Intelligence

Northwestern Medicine Becomes First Health System to Integrate Tempus’ Generative AI Co-Pilot, David, Into Its EHR Platform

September 04, 2025

From Tempus AI, Inc.

Via Business Wire

Tempus to Participate in Morgan Stanley’s 23rd Annual Global Healthcare Conference

September 03, 2025

From Tempus AI, Inc.

Via Business Wire

This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗

September 03, 2025

Via Benzinga

This Unisys Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

September 03, 2025

Via Benzinga

3 Heavily Shorted Stocks That Could Prove the Bears Wrong ↗

September 02, 2025

Bearish investors are hammering these three stocks with short selling. However, all three have promising developments on their side that bears may be missing.

Via MarketBeat

Topics Artificial Intelligence

Forecasting The Future: 5 Analyst Projections For Tempus AI ↗

September 02, 2025

Via Benzinga

This Penumbra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗

September 02, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.